Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid-19 save search
GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox
Published: 2023-12-19 (Crawled : 14:00) - globenewswire.com
GOVX | $1.54 5.48% 5.19% 22K
|
Health Technology
|
| O: 5.76%
H: 0.95%
C: -2.59%
covid-19 license smallpox
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19
Published: 2023-12-18 (Crawled : 12:00) - globenewswire.com
IVVD | $2.365 -4.64% -4.86% 470K
|
Manufacturing
|
| O: 23.93%
H: 133.17%
C: 77.72%
vyd222 covid-19 positive ongoing trial results
NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)
Published: 2023-12-12 (Crawled : 14:00) - globenewswire.com
NURO | $3.63 1.68% 1.65% 10K
|
Health Technology
|
| O: -2.86%
H: 3.24%
C: 2.65%
covid-19 quell trial pilot results
Novavax's Updated COVID-19 Vaccine Now Authorized in Canada
Published: 2023-12-05 (Crawled : 21:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 0.18%
H: 3.93%
C: -0.36%
covid-19 authorized vaccine canada
RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study
Published: 2023-12-04 (Crawled : 13:30) - biospace.com/
RDHL | $0.4301 11.57% 10.37% 660K
|
Health Technology
|
| O: 6.63%
H: 12.99%
C: 6.78%
rhb-107 covid-19 funding study phase 2
Global Freight Trucking Strategic Business Report 2023-2030: Moving Beyond COVID-19, How Will Global Supply Chains Looks Like? The Answer Every Stakeholder in Supply Chain Logistics Should Know
Published: 2023-12-02 (Crawled : 04:20) - prnewswire.com
EXPD 4 | $114.76 0.37% 0.21% 840K
|
Transportation
| Email alert
Add to watchlist
CNI | News | $127.16 0.1% 0.01% 710K
|
Transportation
| Email alert
Add to watchlist
covid-19 report business beyond freight global
Global Steel Scrap Industry Report 2023-2030: High Volume Opportunities to Re-Emerge in Shipping Sector in Post COVID-19 Environment
Published: 2023-12-01 (Crawled : 00:20) - prnewswire.com
AMSIY | News | $0.1305 0
|
Manufacturing
| Email alert
Add to watchlist
NUE | News | $190.77 -1.04% -0.4% 1M
|
Non-Energy Minerals
| Email alert
Add to watchlist
STLD | $136.07 -2.06% -2.1% 1.3M
|
Non-Energy Minerals
| Email alert
Add to watchlist
MT | News | $25.15 0.16% 0.0% 2.8M
|
Non-Energy Minerals
| Email alert
Add to watchlist
ARCXF | News | $0.05 309.0% 10K
|
Non-Energy Minerals
| Email alert
Add to watchlist
ALCO | $26.8 0.56% 0.56% 17K
|
Process Industries
| Email alert
Add to watchlist
AMSYF | News | $26.89 -10.71% 200
|
Non-Energy Minerals
| Email alert
Add to watchlist
CMC | $55.28 -1.06% -1.99% 720K
|
Non-Energy Minerals
| Email alert
Add to watchlist
covid-19 report global
South Africa Air Compressor Market Report 2023-2029 | Value, Industry, Companies, COVID-19 IMPACT, Growth, Trends, Size, Revenue, Share, Forecast & Analysis
Published: 2023-11-29 (Crawled : 17:00) - prnewswire.com
IR | News | $88.97 -0.67% 0.0% 1.2M
|
Producer Manufacturing
|
| O: 0.79%
H: 0.27%
C: -0.87%
covid-19 air report market africa
GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress
Published: 2023-11-28 (Crawled : 14:00) - globenewswire.com
GOVX | $1.54 5.48% 5.19% 22K
|
Health Technology
|
| O: -2.52%
H: 14.22%
C: 5.39%
covid-19 vaccine congress world
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
Published: 2023-11-28 (Crawled : 11:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 1.1%
H: 5.07%
C: 3.8%
covid-19 vaccine health world
Global Protective Eyewear Strategic Market Report 2022 & 2023-2030: Manufacturing Industry Remains Important Consumer of Protective Eyewear Despite COVID-19 Backlash
Published: 2023-11-14 (Crawled : 01:00) - prnewswire.com
CAH | $106.0 -0.49% -0.94% 1.5M
|
Distribution Services
|
| O: -0.57%
H: 0.24%
C: -1.38%
MMM | $91.48 0.57% 0.0% 3M
|
Producer Manufacturing
|
| O: 1.41%
H: 1.59%
C: 1.03%
covid-19 report global market
Global Self Testing Market Analysis Report 2023-2028: Breakdown by Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, & COVID-19 Testing
Published: 2023-11-08 (Crawled : 10:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.4%
H: 0.32%
C: -0.66%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.04%
H: 0.54%
C: -0.5%
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: -0.15%
H: 1.46%
C: -1.98%
OSUR | $5.25 0.0% 660K
|
Health Technology
|
| O: 1.04%
H: 6.04%
C: 1.81%
covid-19 pregnancy report urine cholesterol blood global market
Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
VERV | $6.66 -1.19% -1.2% 1.2M
|
Professional, Scientific, and T...
|
| O: 0.37%
H: 0.64%
C: -10.76%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.46%
H: 0.46%
C: -0.23%
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.01%
H: 0.03%
C: -3.14%
CVAC | News | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 0.91%
H: 1.08%
C: -1.44%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -2.81%
ARCT 4 | $26.31 -4.81% -5.06% 610K
|
Health Technology
|
| O: -0.36%
H: 0.79%
C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market
COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published: 2023-11-06 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.11%
H: 0.33%
C: -0.98%
TEVA | $12.78 -3.03% -0.24% 9M
|
Health Technology
|
| O: 0.22%
H: 1.49%
C: -0.33%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.44%
H: 0.22%
C: 0.07%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.24%
H: 0.18%
C: 0.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.55%
H: 0.3%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
covid-19
Analysis of COVID-19|Growing prominence of online shopping is driving the market growth - Technavio
Published: 2023-11-02 (Crawled : 03:00) - prnewswire.com
BABAF | News | $8.56 2.05% 210K
|
Retail Trade
|
| O: -0.98%
H: 4.15%
C: 1.57%
LULU | $347.5 0.77% 0.76% 2.2M
|
Retail Trade
|
| O: 0.92%
H: 1.49%
C: 1.15%
covid-19 growth market
CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK
Published: 2023-11-01 (Crawled : 14:00) - biospace.com/
CVAC | News | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 0.19%
H: 3.95%
C: -1.32%
covid-19 collaboration phase 2
CureVac meldet Fortschritte in klinischen Phase-2-Entwicklungsprogrammen für COVID-19 und die saisonale Grippe in Zusammenarbeit mit GSK
Published: 2023-11-01 (Crawled : 13:00) - curevac.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -4.06%
H: 1.9%
C: 0.96%
CVAC | News | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 0.19%
H: 3.95%
C: -1.32%
covid-19 phase 2
Novavax's Updated COVID-19 Vaccine Now Approved in the EU
Published: 2023-10-31 (Crawled : 21:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 0.6%
H: 5.22%
C: 4.48%
covid-19 vaccine approved
Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU
Published: 2023-10-31 (Crawled : 17:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -0.46%
H: 5.24%
C: 2.62%
covid-19 chmp vaccine positive
GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine
Published: 2023-10-30 (Crawled : 13:00) - globenewswire.com
GOVX | $1.54 5.48% 5.19% 22K
|
Health Technology
|
| O: 0.0%
H: 2.02%
C: -1.42%
covid-19 vaccine expansion trial phase 2
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.